Use of peptides and peptide libraries as T-cell stimulants in flow cytometric studies

Methods in Cell Biology

Volumn 2004, Issue 75, 2004, Pages 453-479

  Cherepnev, Georgy ^a   Volk, Hans Dieter ^a   Kern, Florian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PEPTIDE; PEPTIDE LIBRARY; SOLVENT;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; CIRCADIAN RHYTHM; EPITOPE MAPPING; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; INFECTION; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SYNTHESIS; T LYMPHOCYTE; TIME; VACCINATION; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CIRCADIAN RHYTHM; CYTOKINES; EPITOPE MAPPING; FLOW CYTOMETRY; HUMANS; IMMUNITY; IMMUNOCOMPROMISED HOST; INFECTION; LYMPHOCYTE ACTIVATION; MONITORING, IMMUNOLOGIC; PEPTIDE LIBRARY; PEPTIDES; REPRODUCIBILITY OF RESULTS; SOLVENTS; T-LYMPHOCYTES; TIME FACTORS; VACCINATION; VIRUS DISEASES;

EID: 16644393825     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)75018-9     Document Type: Review

References (61)

1. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J I., McMichael, A. J., and Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes [published erratum in Science 1998;274:94-96]. Science 280, 1821.
2. Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M., Dong, T., King, A., Ogg, G. S., Spiegel, H. M., Conlon, C., Spina, C. A., Havlir, D. V., Richman, D. D., Waters, A., Easterbrook, P., McMichael, A. J., and Rowland-Jones, S. L. (2000). HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192, 63-75.
3. Barry, S. M., Lipman, M. C., Johnson, M. A., and Prentice, H. G. (1999). Respiratory infections in immunocompromised patients. Curr. Opin. Pulm. Med. 5, 168-173.
4. Betts, M. R., Casazza, J. P., Patterson, B. A., Waldrop, S., Trigona, W., Fu, T. M., Kern, F., Picker, L. J., and Koup, R. A. (2000). Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J. Virol. 74, 9144-9151.
5. Bhargava, S., Licha, K., Knaute, T., Ebert, B., Becker, A., Grotzinger, C., Hessenius, C., Wiedenmann, B., Schneider-Mergener, J., and Volkmer-Engert, R. (2002). A complete substitutional analysis of VIP for better tumor imaging properties. J. Mol. Recognit. 15, 145-153.
6. Boeckh, M., and Boivin, G. (1998). Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11, 533-554.
7. Carson, R. T., and Vignali, D. A. (1999). Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 227, 41-52.
8. De Rosa, S. C., Brenchley, J. M., and Roederer, M. (2003). Beyond six colors: a new era in flow cytometry. Nat. Med. 9, 112-117.
9. Diamond, D. J., York, J., Sun, J. Y., Wright, C. L., and Forman, S. J. (1997). Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90, 1751-1767.
10. Dunn, H. S., Haney, D. J., Ghanekar, S. A., Stepick-Biek, P., Lewis, D. B., and Maecker, H. T. (2002). Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J. Infect. Dis. 186, 15-22.
11. Ede, N. J. (2002). Multiple parallel synthesis of peptides on SynPhase grafted supports. J. Immunol. Methods 267, 3-11.
12. Frank, R. (2002). The SPOT-synthesis technique. Synthetic peptide arrays on membrane suports-principles and apllications. J. Immunol. Methods 267, 13-26.
13. Gatell, J. M., Marrades, R., el-Ebiary, M., and Torres, A. (1996). Severe pulmonary infections in AIDS patients. Semin. Respir. Infect. 11, 119-128.
14. Gratama, J. W., van Esser, J. W., Lamers, C. H., Tournay, C., Lowenberg, B., Bolhuis, R. L., and Cornelissen, J. J. (2001). Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98, 1358-1364.
15. Hebart, H., Daginik, S., Stevanovic, S., Grigoleit, U., Dobler, A., Baur, M., Rauser, G., Sinzger, C., Jahn, G., Loeffler, J., Kanz, L., Rammensee, H. G., and Einsele, H. (2002). Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme- linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99, 3830-3837.
16. Hiemke, C., Brunner, R., Hammes, E., Muller, H., Meyer zum Buschenfelde, K. H., and Lohse, A. W. (1995). Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production. Psychoneuroendocrinology 20, 335-342.
17. Hoffmeister, B., Kiecker, F., Tesfa, L., Volk, H. D., Picker, L. J., and Kern, F. (2003). Mapping T cell epitopes by flow cytometry. Methods 29, 270-281.
18. Karanikas, V., Lodding, J., Maino, V. C., and McKenzie, I. F. (2000). Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin. Cancer Res. 6, 829-837.
19. Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Khatamzas, E., Rudawski, I. M., Pruss, A., Gratama, J. W., Volkmer-Engert, R., Ewert, R., Reinke, P., Volk, H. D., and Picker, L. J. (2002). Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185, 1709-1716.
20. Kern, F., Faulhaber, N., Frömmel, C., Khatamzas, E., Prösch, S., Schönemann, C., Kretzschmar, I., Volkmer-Engert, R., Volk, H.-D., and Reinke, P. (2000). Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30, 1676-1682.
21. Kern, F., Faulhaber, N., Khatamzas, E., Frommel, C., Ewert, R., Frosch, S., Volk, H., and Reinke, P. (1999a). Measurement of anti-human cytomegalovirus T cell reactivity in transplant recipients and its potential clinical use: a mini-review. Intervirology 42, 322-324.
22. Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., Walden, P., and Volk, H. D. (1998). T-cell epitope mapping by flow cytometry. Nat. Med. 4, 975-978.
23. Kern, F., Surel, I. P., Faulhaber, N., Frommel, C., Schneider-Mergener, J., Schonemann, C., Reinke, P., and Volk, H. D. (1999b). Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73, 8179-8184.
24. Knabel, M., Franz, T. J., Schiemann, M., Wulf, A., Villmow, B., Schmidt, B., Bernhard, H., Wagner, H., and Busch, D. H. (2002). Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8, 631-637.
25. Kostense, S., Otto, S.A., Knol, G. J., Manting, E. H., Nanlohy, N. M., Jansen, C., Lange, J. M., van Oers, M. H., Miedema, F., and van Baarle, D. (2002a). Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Eur. J. Immunol. 32, 1080-1089.
26. Kostense, S., Vandenberghe, K., Joling, J., Van Baarle, D., Nanlohy, N., Manting, E., and Miedema, F. (2002b). Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood 99, 2505-2511.
27. Latt, S. A., George, Y. S., and Gray, J. W. (1977). Flow cytometric analysis of bromodeoxyuridine-substituted cells stained with 33258 Hoechst. J. Histochem. Cytochem. 25, 927-934.
28. Lebowitz, M. S., O'Herrin, S. M., Hamad, A. R., Fahmy, T., Marguet, D., Barnes, N. C., Pardoll, D., Bieler, J. G., and Schneck, J. P. (1999). Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. Cell Immunol. 192, 175-184.
29. Lecoeur, H., Fevrier, M., Garcia, S., Riviere, Y., and Gougeon, M. L. (2001). A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253, 177-187.
30. Lyons, A. B. (2000). Analyzing cell division in viro and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243, 147-154.
31. Maecker, H. T., Auffermann-Gretzinger, S., Nomura, L. E., Liso, A., Czerwinski, D. K., and Levy, R. (2001a). Detection of CD4 T-cell responses to a tumor vaccine by cytokine flow cytometry. Clin. Cancer Res. 7, 902s-908s.
32. Maecker, H. T., Dunn, H. S., Suni, M. A., Khatamzas, E., Pitcher, C. J., Bunde, T., Persaud, N., Trigona, W., Fu, T. M., Sinclair, E., Bredt, B. M., McCune, J. M., Maino, V. C., Kern, F., and Picker, L. J. (2001b). Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255, 27-40.
33. Maeji, N. J., Bray, A. M., and Geysen, H. M. (1990). Multi-pin peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods 134, 23-33.
34. Maeji, N. J., Bray, A. M., Valerio, R. M., and Wang, W. (1995). Larger scale multipin peptide synthesis. Pept. Res. 8, 33-38.
35. Maino, V. C., and Picker, L. J. (1998). Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression. Cytometry 34, 207-215.
36. Mollet, L., Li, T. S., Samri, A., Tournay, C., Tubiana, R., Calvez, V., Debre, P., Katlama, C., and Autran, B. (2000). Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load. The RESTIM and COMET Study Groups. J. Immunol. 165, 1692-1704.
37. Nielsen, M. B., Monsurro, V., Migueles, S. A., Wang, E., Perez-Diez, A., Lee, K. H., Kammula, U., Rosenberg, S. A., and Marincola, F. M. (2000). Status of activation of circulating vaccine-elicited CD8+ T cells. J. Immunol. 165, 2287-2296.
38. Oxenius, A., Sewell, A. K., Dawson, S. J., Gunthard, H. F., Fischer, M., Gillespie, G. M., Rowland-Jones, S. L., Fagard, C., Hirschel, B., Phillips, R. E., and Price, D. A. (2002). Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. J. Clin. Immunol. 22, 363-374.
39. Ozdemir, E., St John, L. S., Gillespie, G., Rowland-Jones, S., Champlin, R. E., Molldrem, J. J., and Komanduri, K. V. (2002). Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 100, 3690-3697.
40. Parslow, T., Stites, D., Terr, A., and Imboden, J. (2001). Medical immunology. In McGraw-Hill Companies, East Norwalk, Connecticut, USA.
41. Picker, L. J., Singh, M. K., Zdraveski, Z., Treer, J. R., Waldrop, S. L., Bergstresser, P. R., and Maino, V. C. (1995). Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86, 1408-1419.
42. Pitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C., and Picker, L. J. (1999). HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5, 518-525.
43. Pittet, M. J., Speiser, D. E., Lienard, D., Valmori, D., Guillaume, P., Dutoit, V., Rimoldi, D., Lejeune, F., Cerottini, J. C., and Romero, P. (2001a). Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide. Clin. Cancer Res. 7, 796s-803s.
44. Pittet, M. J., Zippelius, A., Speiser, D. E., Assenmacher, M., Guillaume, P., Valmori, D., Lienard, D., Lejeune, F., Cerottini, J. C., and Romero, P. (2001b). Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166, 7634-7640.
45. Rammensee, H. G., Bachmann, J., and Stefanovic, S. (1997). MHC ligands and binding motifs. Landes Bioscience, Georgetown, Texas.
46. Reineke, U., Volkmer-Engert, R., and Schneider-Mergener, J. (2001). Applications of peptide arrays prepared by the SPOT-technology. Curr. Opin. Biotechnol. 12, 59-64.
47. Reineke, U., Ivascu, C., Schlief, M., Landgraf, C., Gericke, S., Zahn, G., Herzel, H., Volkmer-Engert, R., and Schneider-Mergener, J. (2002). Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J. Immunol. Methods. 267, 37-51.
48. Reusser, P., Cathomas, G., Attenhofer, R., Tamm, M., and Thiel, G. (1999). Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J. Infect. Dis. 180, 247-253.
49. Riddell, S. R., and Greenberg, P. D. (1995). Cellular adoptive immunotherapy after bone marrow transplantation. Cancer Treat. Res. 76, 337-369.
50. Riddell, S. R., Walter, B. A., Gilbert, M. J., and Greenberg, P. D. (1994). Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. Bone Marrow Transplant. 14(Suppl. 4), S78-S84.
51. Scheffold, A., Lohning, M., Richter, A., Assenmacher, M., Manz, R., Austrup, F., Hamann, A., and Radbruch, A. (1998). Analysis and sorting of T cells according to cytokine expression. Eur. Cytokine Netw. 9, 5-11.
52. Scheibenbogen, C., Letsch, A., Thiel, E., Schmittel, A., Mailaender, V., Baerwolf, S., Nagorsen, D., and Keilholz, U. (2002). CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 100, 2132-2137.
53. Smith, J. W., 2nd, Walker, E. B., Fox, B. A., Haley, D., Wisner, K. P., Doran, T., Fisher, B., Justice, L., Wood, W., Vetto, J., Maecker, H., Dols, A., Meijer, S., Hu, H. M., Romero, P., Alvord, W. G., and Urba, W. J. (2003). Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp 100 peptide induces peptide-specific CD8+ T-cell responses. J. Clin. Oncol. 21, 1562-1573.
54. Tesfa, L., Koch, F., Pankow, W., Volk, H., and Kern, F. (2004). Confirmation of Mycobacterium tuberculosis infection by flow-cytometry after ex-vivo incubation of peripheral blood T cells with an ESAT6 derived peptide pool. Cytometry 60B(1), 47-53.
55. Tesfa, L., Volk, H. D., and Kern, F. (2003). Comparison of proliferation and rapid cytokine induction assays for flow cytometric T-cell epitope mapping. Cytometry 52A, 36-45.
56. Tribbick, G. (2002). Multipin peptide libraries for antibody and receptor epitope screening and characterization. J. Immunol. Methods 267, 27-35.
57. Valmori, D., Scheibenbogen, C., Dutoit, V., Nagorsen, D., Asemissen, A. M., Rubio-Godoy, V., Rimoldi, D., Guillaume, P., Romero, P., Schadendorf, D., Lipp, M., Dietrich, P. Y., Thiel, E., Cerottini, J. C., Lienard, D., and Keilholz, U. (2002). Circulating tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res. 62, 1743-1750.
58. Waldrop, S. L., Davis, K. A., Maino, V. C., and Picker, L. J. (1998). Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 161, 5284-5295.
59. Waldrop, S. L., Pitcher, C. J., Peterson, D. M., Maino, V. C., and Picker, L. J. (1997). Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99, 1739-1750.
60. Wenschuh, H., Volkmer-Engert, R., Schmidt, M., Schulz, M., Schneider-Mergener, J., and Reineke, U. (2000). Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers 55, 188-206.
61. Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., and Sissons, J. G. (1996). The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70, 7569-7579.